Stay updated on Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision metadata was updated from v3.5.2 to v3.5.3 on the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.0%

- Check55 days agoChange DetectedNapoli, Italy, 80131 has been changed to Naples, Italy, 80131. The revision label has been updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page revision updated from v3.4.1 to v3.4.2; this appears to be a minor version update with no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check98 days agoChange DetectedAdded Primary peritoneal carcinoma to the Conditions and introduced a new Resources link to the Genetic and Rare Diseases Information Center. Page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.